Streetbeat News

Products Services

APPN

Appian Corporation (APPN) exceeded third-quarter earnings expectations with a 22% year-over-year increase, surpassing both top and bottom lines. CEO Matt Calkins attributes this success to a focus on profitability, securing large deals, and advancements in agentic AI.

Portfolio Pulse from

November 17, 2024 | 9:15 pm

AAPL

The article discusses the potential long-term benefits of investing in Apple Inc. (AAPL) today, suggesting that it could be a lucrative decision for investors.

Portfolio Pulse from

November 17, 2024 | 8:15 pm

QCOM

The article discusses the ongoing boom in the Artificial Intelligence (AI) industry, highlighting its potential to become a multitrillion-dollar market. It suggests that there are still high-quality AI stocks with significant upside potential for investors.

Portfolio Pulse from

November 17, 2024 | 5:15 pm

BMY

Bristol-Myers Squibb's stock has increased by over 25% in the past six months due to advancements in oncology and neuroscience. Yervoy's sales rose by 10.9% year-on-year in Q3 2024. The company also received approval for Cobenfy, a schizophrenia treatment.

Portfolio Pulse from

November 17, 2024 | 5:00 pm

MSFT

Microsoft reported a 16% year-over-year revenue growth in Q1 2025, reaching $65.6 billion, driven by cloud and AI services. Azure saw a 33% growth, with AI services contributing 12%. The company's 98% annuity-based revenue model and $259 billion in remaining performance obligations ensure stable future income.

Portfolio Pulse from

November 17, 2024 | 5:00 pm

BVNKF

Bavarian Nordic's mpox vaccine sales have decreased following the outbreak, leading to reduced revenue and emphasizing the company's dependence on outbreak-driven demand. However, the Travel Health segment showed strength with a 21% YoY revenue increase, driven by rabies and tick-borne encephalitis vaccines. Bavarian Nordic is diversifying with the launch of a chikungunya vaccine, targeting a $500 million market by 2032.

Portfolio Pulse from

November 17, 2024 | 4:45 pm

AMZN

Amazon is experiencing significant growth in its AWS segment, driven by increased demand for AI and cloud services. Retail sales have also accelerated, particularly in private label brands, as budget-conscious consumers increase purchases.

Portfolio Pulse from

November 17, 2024 | 4:15 pm

SMIG

The Bahl & Gaynor Small/Mid Cap Income Growth ETF (SMIG) is highlighted for its focus on small and mid-cap companies with strong income growth potential. The ETF's strategy includes a concentrated portfolio with a sector allocation in Industrials and Financials, aiming for steady dividends and capital appreciation.

Portfolio Pulse from

November 17, 2024 | 4:00 pm

MYGN

Levi & Korsinsky has initiated an investigation into Myriad Genetics, Inc. for potential securities law violations. This follows UnitedHealth Group's decision to stop covering Myriad's GeneSight test from January 2025.

Portfolio Pulse from

November 17, 2024 | 4:00 pm

NRIX

Nurix Therapeutics presented preclinical data at ACR Convergence 2024, showcasing the potential superiority of their targeted protein degradation strategy over kinase inhibition for BTK and IRAK4 targets in autoimmune and inflammatory diseases.

Portfolio Pulse from

November 17, 2024 | 3:45 pm